Pharmacogenomics of Hypertension in Africa: Paving the Way for a Pharmacogenetic-Based Approach for the Treatment of Hypertension in Africans
In Africa, the burden of hypertension has been rising at an alarming rate for the last two decades and is a major cause for cardiovascular disease (CVD) mortality and morbidity. Hypertension is characterised by elevated blood pressure (BP) ≥ 140/90 mmHg. Current hypertension guidelines recommend the...
Saved in:
| Main Authors: | Jonathan N. Katsukunya, Nyarai D. Soko, Jashira Naidoo, Brian Rayner, Dirk Blom, Phumla Sinxadi, Emile R. Chimusa, Michelle Dandara, Kevin Dzobo, Erika Jones, Collet Dandara |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-01-01
|
| Series: | International Journal of Hypertension |
| Online Access: | http://dx.doi.org/10.1155/2023/9919677 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
NOS3 rs3918188C>A is associated with susceptibility to resistant hypertension while CES1 genetic variation was not associated with resistant hypertension among South Africans
by: Jonathan N. Katsukunya, et al.
Published: (2025-06-01) -
Editorial: Insights in pharmacogenetics and pharmacogenomics: 2023
by: José A. G. Agúndez, et al.
Published: (2025-01-01) -
Implementing health economics for pharmacogenomics research translation in Africa
by: Mohamed Zahir Alimohamed, et al.
Published: (2025-06-01) -
Pharmacokinetics, pharmacogenetics, and toxicity of co-administered efavirenz and isoniazid
by: Jessica Taylor, et al.
Published: (2025-03-01) -
Editorial: Editor’s feature: negative findings in pharmacogenetics and pharmacogenomics volume II
by: José A. G. Agúndez, et al.
Published: (2025-07-01)